Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

LGBTQ+

China flag thumb

Sanjing Pharma chief leaps to his death amid corruption probe

Liu Zhanbin was chairman and chief executive of the Harbin Pharmaceutical Group subsidiary

EU flag

EU approval for J&J’s hepatitis C drug

Olysio can be used in combination with Gilead’s Sovaldi

- PMLiVE

Medicus International rebrands as Discovery London

Med comms agency is also promoted to European hub for Publicis' Discovery network

Pharma deals during April 2014

Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month

Deal Watch table for April 2014

Table listing all the major pharma mergers, acquisitions and collaborations in the past month

- PMLiVE

Havas Worldwide appoints healthcare head in SE Asia

Victor Joseph ‘VJ’ Yamat is managing director of healthcare operations in emerging region

- PMLiVE

Theories abound after Publicis/Omnicom merger breaks down

Firms end talks to become world’s largest advertising agency

- PMLiVE

Unions blast ‘negative consequences’ for Sweden of a Pfizer-AZ deal

Say proposed takeover posed an imminent risk to country's life science sector

- PMLiVE

Eisai resubmits Fycompa to G-BA for pricing assessment

But German distribution of epilepsy drug remains on hold until reimbursement settled

- PMLiVE

Abbott strikes $3.3bn Latin America generics deal

Boosts portfolio in region with acquisition of CFR Pharmaceuticals

- PMLiVE

AstraZeneca rejects ‘final offer’ from Pfizer

And US pharma company rules out hostile takeover

Novartis building

FDA rejects Novartis’ breakthrough heart failure drug

Regulator wants more data on serelaxin

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links